International Journal of Trichology International Journal of Trichology
 Print this page Email this page Small font sizeDefault font sizeIncrease font size
  Home | About IJT | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Online submission | Subscribe | Advertise | Contact us | Login   

    Article Cited by others


Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients

Shivanna Chandrashekar Byalekere, Shenoy Chaithra, Priya R Arti

Year : 2018| Volume: 10| Issue : 3 | Page no: 103-107

   This article has been cited by
1 Physiotherapeutic methods in the complex treatment of alopecia
Vera Vasilievna Kiryanova, Yulia Sergeevna Egorova , Elena Vadimovna Petrova, Alla Askoldovna Potapchuk , Antonina Anatolievna Chaban
Fizioterapevt (Physiotherapist). 2022; (01): 68
[Pubmed]  [Google Scholar] [DOI]
2 Inhibidores de JAK: usos en dermatología. Parte 1: generalidades, aplicaciones en vitíligo y en alopecia areata
C. Garcia-Melendo, X. Cubiró, L. Puig
Actas Dermo-Sifiliográficas. 2021; 112(6): 503
[Pubmed]  [Google Scholar] [DOI]
3 Janus Kinase Inhibitors in Dermatology: Part 1 — General Considerations and Applications in Vitiligo and Alopecia Areata
C. Garcia-Melendo, X. Cubiró, L. Puig
Actas Dermo-Sifiliográficas (English Edition). 2021; 112(6): 503
[Pubmed]  [Google Scholar] [DOI]
4 Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
Emma Guttman-Yassky, Ana B. Pavel, Aisleen Diaz, Ning Zhang, Ester Del Duca, Yeriel Estrada, Brett King, Anindita Banerjee, Christopher Banfield, Lori Ann Cox, Martin E. Dowty, Karen Page, Michael S. Vincent, Weidong Zhang, Linda Zhu, Elena Peeva
Journal of Allergy and Clinical Immunology. 2021;
[Pubmed]  [Google Scholar] [DOI]
5 Off-label studies on tofacitinib in dermatology: a review
Kyle Tegtmeyer, Jeffrey Zhao, Nolan J. Maloney, Giancarlo Atassi, Molly Beestrum, Peter A. Lio
Journal of Dermatological Treatment. 2021; 32(4): 399
[Pubmed]  [Google Scholar] [DOI]
6 Alopecia areata and tofacitinib: a prospective multicenter study from a Saudi population
Alanoud AlMarzoug, May AlOrainy, Lama AlTawil, Ghada AlHayaza, Rasha AlAnazi, Ahmed AlIssa, Afaf AlSheikh, Abdullah AlKhalifah, Ruaa AlHarithy
International Journal of Dermatology. 2021;
[Pubmed]  [Google Scholar] [DOI]
7 A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
Kerry-Ann L Dillon
Clinical, Cosmetic and Investigational Dermatology. 2021; Volume 14: 691
[Pubmed]  [Google Scholar] [DOI]
8 Treatment outcome of oral tofacitinib and ruxolitinib in patients with alopecia areata: A systematic review and meta-analysis
Da-Ae Yu, Ye Eun Kim, Ohsang Kwon, Hyunsun Park
Indian Journal of Dermatology, Venereology and Leprology. 2021; 87: 621
[Pubmed]  [Google Scholar] [DOI]


Read this article